Articles tagged with Covid 19 Vaccines
A nationwide cohort study of 1 million adults found no increased risk of 29 adverse events after vaccination with the updated COVID-19 mRNA vaccine containing the SARS-CoV-2 Omicron JN.1 lineage. The study provides reassuring safety data on the new vaccine, which has been widely adopted in response to the Omicron variant
A comparative effectiveness study estimates that COVID-19 vaccinations averted 2.5 million deaths during 2020-2024, with the majority of benefits secured for older adults within this age group.
Researchers at the University of Pennsylvania designed a new recipe for mRNA vaccines by adding phenol groups, which reduce inflammation and improve vaccine effectiveness. The modified lipids improved vaccine performance in various diseases, including COVID-19, cancer, and genetic diseases, with enhanced efficacy and reduced side effects.
This study found that Black and Hispanic children were disproportionately hospitalized for COVID-19 and experienced severe disease compared to white and Asian or Pacific Islander children. Children with underlying medical conditions from these groups also had a higher proportion of hospitalizations.
A new analysis has found a higher risk of arterial and venous thrombosis after COVID-19 infection compared to vaccination. The study also identified an increased risk of thrombosis following the first dose of the AZD1222 vaccine, but not with subsequent doses.
The study found that 2023-2024 COVID-19 vaccines provide additional protection against medically attended COVID-19 and critical illness. These results highlight the significance of receiving recommended COVID-19 vaccinations for adults 18 years or older, contributing to improved public health outcomes.
The American Medical Association (AMA) emphasizes the importance of COVID-19 vaccination during pregnancy, citing benefits and risks. Physicians should counsel patients on vaccine safety, considering individual factors and potential risks.
Scientists have modified mRNA vaccines to include the cytokine IL-12, enhancing T cell responses and improving protection against diseases such as SARS-CoV-2, influenza, melanoma, and listeria infection. The study's findings suggest a promising approach to enhance immune stimulation against cancer and other pathogens.
A new mRNA vaccine has shown to be more effective and less costly to develop, inducing a robust immune response against SARS-CoV-2 variants. The vaccine's trans-amplifying platform allows for reduced production costs and potential broad protection.
A study by researchers at the University of Arizona Health Sciences found that vaccinated people generated an overall protective immune response to Delta and Omicron strains, with slightly fewer antibodies for the mutated parts of the virus. The research suggests that immune changes due to antigenic imprinting may not be a significant ...
A national study in Sweden reveals that COVID-19 vaccination levels among older people have become increasingly uneven, with regional and socio-economic differences emerging. The study found lower vaccination rates among certain groups, including those born outside Sweden, men, and individuals with low income and education.
The study found that mRNA-1083 induced higher immune responses than standard care influenza and COVID-19 vaccines, with an acceptable tolerability and safety profile. The vaccine met noninferiority criteria for all 4 influenza strains and SARS-CoV-2 across various age groups.
A groundbreaking study from the University of Virginia Health System reveals distinct immune patterns in patients with persistent breathing issues after COVID-19. The research identifies specific T cell changes linked to lung damage and fibrosis, paving the way for personalized treatments.
A cohort study found that vaccination against influenza alone or with COVID-19 was associated with a small but temporary change in menstrual cycle length. This finding may help clinicians confirm the utility of vaccination for patients concerned about menstrual side effects.
The BNT162b2 vaccine not only targets the COVID-19 virus but also helps reduce and control innate inflammation to other bacterial and fungal pathogens. By reprogramming innate immune cells, the vaccine reduces pro-inflammatory mediators, providing potential benefits beyond its primary target.
A new study from Murdoch University confirms that COVID-19 vaccinations do not cause significant metabolic changes. The research monitored 167 metabolic markers in 33 participants over 480 days post-vaccination, showing no significant impact on key health indicators.
Researchers found a significant difference in parental support for adolescent consent when the question was framed using "Mature Minor Doctrine" versus describing specific scenarios. The study suggests that clear and detailed information can greatly impact parents' opinions on these issues.
New research found that COVID vaccines significantly reduced the risk of long COVID in children and adolescents. Vaccination was about 95% effective in preventing long COVID in some cohorts, primarily due to its ability to prevent initial infection.
A new study reveals that the US national vaccine strategy saved more money than it spent on testing, buying and delivering COVID-19 vaccines after just one year. The analysis found that the vaccines reduced serious illness and deaths, resulting in significant cost savings.
Researchers at HKU and CVVT create a nasal spray vaccine offering single-dose protection against H5N1 infection, inducing comprehensive immunity in the upper respiratory tract. The vaccine's high safety profile and ability to curb viral transmission make it a critical reserve for future outbreaks.
A study of 113 healthcare workers found that COVID-19 mRNA vaccination induces long-lasting antibody and memory B-cell responses, even in those previously exposed to the virus. The research team also discovered an association between higher levels of specific antibodies and increased risk of breakthrough infections.
The Vaccine Innovation Center at Korea University's College of Medicine successfully held the 2025 Vaccine Expert Training Program, attended by over 380 experts and researchers from various fields. The program aims to foster domestic vaccine R&D experts and promote the development of commercially available vaccines.
Researchers have discovered a key cellular mechanism regulating mRNA vaccine delivery and stability, proposing a new paradigm for mRNA therapeutics. The study highlights the importance of N1-methylpseudouridine modification in enhancing mRNA vaccine effectiveness.
A new study suggests that blood cancer patients receiving Bruton Tyrosine Kinase inhibitors should continue their therapy while getting vaccinated against COVID-19. The IMPROVE trial found no improvement in antibody responses when BTKi therapy was paused for three weeks around the time of vaccination.
A new study by researchers at McGill University found that annual COVID-19 vaccine booster doses help avoid breakthrough infections in people with immune-mediated inflammatory diseases. The study tracked 366 patients across Canada and used saliva PCR tests and antibody measurements, offering a more precise picture of infection risks.
The University of Texas at Arlington expert discusses the state's largest outbreak in 30 years, with fewer people getting vaccinated contributing to its spread. The MMR vaccine is 97% effective against measles and has been proven safe despite misconceptions about its safety.
Researchers at Lancaster University discovered a new type of vaccine-specific scepticism, where some people perceive COVID-19 vaccines as 'not a vaccine' compared to MMR. This phenomenon may also apply to the flu vaccine, highlighting the need for clear public health messaging.
Researchers found that mRNA-based COVID-19 vaccines cause persistent epigenetic changes in monocyte-derived macrophages, enabling a sustained immune response. These changes were preserved for six months after vaccination and required multiple doses to maintain long-term immunity.
Researchers developed a universal vaccine that removes sugar molecules from coronavirus spike proteins, creating effective antibodies. The vaccine showed improved protection against various variants and potential applications for cancer treatment.
A major clinical trial has identified ensitrelvir as an effective medication to prevent symptomatic COVID-19 in people exposed within households. The trial showed a 67% reduction in risk of illness among participants taking the antiviral compared to those given a placebo.
A new study published in PLOS Medicine estimates that the COVID-19 pandemic cost Europe 16.8 million disability-free years of life between 2020 and 2022. The study found that more than half of these lost years would have been lived without disability, highlighting the pandemic's long-term impact on older populations.
A Canadian-developed, needle-free COVID-19 vaccine has begun phase-2 human trials, testing its efficacy and safety in a broad study group. The trial aims to evaluate the vaccine's ability to induce immune responses and prevent recurrent infections, with researchers hoping to include 350 participants from across Canada.
Researchers developed a new vaccine platform that provides robust, long-lasting protection against multiple flu strains and COVID-19. The vaccine boasts 100% survival rates in vaccinated mice following challenge with either virus.
Researchers report an increase in adult VZV-related CNS infections, particularly since 2019, with a notable rise in aseptic meningitis cases. The study suggests that universal varicella vaccination may be contributing to the decline in natural immunity, leading to reactivation and CNS complications.
A cohort study found no increase in sudden cardiac arrest/sudden cardiac death among young competitive athletes in the US, contradicting reports that linked COVID-19 infection and vaccination to the risk. The study suggests that many athlete cases shown in social media videos occurred before the pandemic, not due to COVID-19.
A study published in Nature Cardiovascular Research identified distinct immune signatures in myocarditis caused by SARS-CoV-2 infection and mRNA vaccines compared to non-COVID-19 myocarditis. The findings suggest a stronger immune response in post-COVID-19 myocarditis, while the inflammation appeared milder in post-vaccination cases.
A new study suggests that mRNA COVID-19 vaccination may protect against post-COVID condition symptoms in children. The findings support the benefits of vaccination beyond acute protection, encouraging increased pediatric uptake.
A recent study from the University of Kansas found that people tend to prefer AI chatbots when discussing sensitive or embarrassing topics like health information, due to their anonymity and nonjudgmental nature. However, when individuals are angry, they still prefer human interaction.
New UCLA-led research finds that Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults. The study suggests that Paxlovid's potential effect on COVID-19 hospitalization in vaccinated older adults is four times weaker than originally reported.
A team of researchers has identified a new chronic blood clotting disorder, VITT-like monoclonal gammopathy of thrombotic significance (MGTS), characterized by antibodies similar to those causing vaccine-induced immune thrombocytopenia and thrombosis (VITT). The disorder can lead to severe symptoms despite treatment with full-dose bloo...
Immunocompromised individuals require regular vaccine boosters to protect against severe infections and new variants, research shows. Boosters may need to be administered four or more times to offer adequate protection.
A US clinical trial will assess the safety and efficacy of a nasal COVID-19 vaccine developed using technology from Washington University in St. Louis. The trial, sponsored by the National Institute of Allergy and Infectious Diseases, aims to evaluate the vaccine's ability to induce strong immunity in the nose and upper respiratory tract.
Researchers uncovered eight rare diseases that carry significantly increased risks for COVID-19-related mortality in fully vaccinated individuals. These conditions, including infertility disorders and kidney diseases, pose a nearly fivefold greater risk of death from COVID-19 than the general population.
Scientists at Tel Aviv University successfully transport mRNA-based drugs to the immune system of small and large intestines without passing through the liver. The breakthrough could enable treatments for inflammatory diseases such as Crohn's and colitis.
A new survey finds that nearly three-quarters of US adults support requiring children to be vaccinated against preventable diseases, while over half support prohibiting unvaccinated children from attending school. However, support for this prohibition has dropped significantly since the Covid-19 pandemic, and there is growing support f...
A study of 1,700 people found that those who consumed more conservative news were less likely to be vaccinated, but a diverse media diet made them more likely to get vaccinated. People who got their news from an ideologically diverse array of sources were more critical thinkers and less likely to be misled by misinformation.
Researchers developed a nanoparticle-based vaccine that generates antibodies targeting conserved regions of sarbecovirus receptor-binding proteins, offering broader protection against multiple strains. The vaccine demonstrated strong antibody responses and protection in animal studies against diverse SARS-CoV-2 and other sarbecoviruses.
Researchers created a framework to determine the best vaccination strategy for communities with individuals of different risk levels. The framework prioritizes vaccination efforts for high-risk groups, such as the elderly and immunocompromised, or high-contact groups, like essential workers, over baseline populations.
A recent study by Emory University researchers found that mRNA vaccines developed to fight COVID-19 are less effective in patients with autoimmune diseases like lupus. The findings highlight the importance of developing tailored vaccination strategies for this vulnerable population.
Researchers at the University of São Paulo's Medical School have developed a COVID-19 vaccine using virus-like particles (VLPs), which proved highly protective, safe, and versatile in animal trials. The vaccine can be easily updated to combat variants of concern without requiring an adjuvant.
Researchers found that up to 34% of the British public considered acts like nepotism or bribery acceptable during the vaccine rollout. The study also discovered an association between public tolerance of petty corruption and vaccine rollout speed, with slower rollouts in areas where tolerance was higher. Lead author Dr Franziska Sohns ...
A recent study highlights the need for targeted interventions to improve COVID-19 vaccine confidence among Black women in the US. Addressing historical traumas and providing clear safety information are crucial to building trust with this demographic.
Peter Hotez proposes a focus on local data, improved benefit-risk communications, and state-level action to counter US antivaccine sentiment. Childhood vaccinations are becoming increasingly politicized, with multiple preventable illnesses emerging, including whooping cough and measles.
Researchers found that older adults with weakened immunity developed fewer antibodies against RSV following vaccination compared to healthy individuals. The study suggests that adjuvant-enhanced vaccines could improve immune responses in immunocompromised people, warranting further investigation.
According to a new survey, over half of U.S. adults believe the RSV vaccine is effective in protecting infants from the virus, up from 42% last year. The rise in perceived effectiveness comes as several politicians have cast doubt on the vaccine's safety and efficacy.
Researchers provide comprehensive review of RSV's virology, clinical impact, and prevention strategies, emphasizing the need for effective vaccines to mitigate this critical health need. The review highlights RSV's severe impact on infants, children, and older adults, as well as its potential effects on multiple organs and systems.
Research from Radboud University Medical Center shows that lockdowns during the COVID-19 pandemic strengthened the immune system's response to microorganisms. The study found that after lockdowns, inflammation levels in the body were low but the immune system reacted more intensely to viruses and bacteria.
A recent study in the Netherlands has found that COVID-19 vaccination during pregnancy is not associated with adverse health outcomes in infants. The researchers analyzed data from over 3,600 participants and found no significant associations between maternal COVID-19 vaccination and neonatal health issues, including breathing difficul...
The Pfizer-BioNTech XBB vaccine provided protection against severe COVID-19 cases and hospitalizations among children aged 5-17 during the 2023-2024 season. The vaccine showed an estimated vaccine effectiveness of 63-73% in preventing severe illness.
A study published in PLOS Global Public Health found that individuals with high credulity are more susceptible to fake news and vaccine hesitancy. Mistrust was also linked to conspiracy thinking and difficulty distinguishing between real and fake news, particularly in those exposed to childhood adversity.